WeVote
Log In

Bill

Bill

SB 1102

Vapor products; modifying and adding requirements for certain attestation; requiring certain notice and directing seizure of certain products. Emergency.

2026 Regular Session Introduced by Bill Coleman and 1 co-sponsor

Oklahoma bill strengthens vapor product oversight through stricter manufacturer attestations, mandatory notice requirements, and seizure authority for non-compliant products.

Policy recommendation to the Health and Human Services Oversight committee; Do Pass Alcohol, Tobacco and Controlled Substances
0
WeVote Research Nonpartisan
Bill Summary · SB 1102

Legislative bill overview

SB 1102 modifies Oklahoma's vapor product regulations by strengthening attestation requirements for manufacturers and retailers, establishing new notice procedures, and authorizing seizure of non-compliant products. The bill is classified as emergency legislation, suggesting lawmakers view the measures as time-sensitive public health or safety concerns.

Why is this important

Vapor products remain a contested regulatory area with concerns about youth access, product safety, and manufacturing standards. This bill attempts to close gaps in Oklahoma's existing oversight framework by requiring enhanced verification that products meet state standards and establishing mechanisms to remove potentially harmful products from commerce.

Potential points of contention

  • Compliance burden on retailers: Expanded attestation requirements may increase operational costs for vapor shops, particularly small businesses, and create ambiguity about who bears liability for manufacturer misrepresentation
  • Seizure authority scope: The bill's seizure provisions lack detailed specification about due process protections, appeal mechanisms, and the standard of evidence required before products are confiscated
  • Undefined product standards: The bill references "certain products" requiring seizure but the legislative record doesn't clarify which specific vapor products trigger enforcement or whether standards align with federal FDA regulations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.